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The clinical outcomes of cementless
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patients with reduced bone mineral density
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Abstract
Background: Osteoporosis and osteopenia are conditions characterised by reduced bone mineral density (BMD).
There is concern that bone with reduced BMD may not provide sufficient fixation for cementless components
which primarily rely on the quality of surrounding bone. The aim of our study was to report the midterm clinical
outcomes of patients with reduced BMD undergoing cementless unicompartmental knee replacements (UKR). Our
hypothesis was that there would be no difference in outcome between patients with normal bone and those with
reduced BMD.
Methods: From a prospective cohort of 70 patients undergoing cementless UKR surgery, patients were categorised
into normal (n = 20), osteopenic (n = 38) and osteoporotic groups (n = 12) based on their central dual-energy X-ray
absorptiometry (DEXA) scans according to the World Health Organization criteria. Patients were followed up by
independent research physiotherapists and outcome scores; Oxford Knee Score (OKS), Tegner score, American Knee
Society Score Functional (AKSS-F) and Objective (AKSS-O) were recorded preoperatively and at a mean of 4 years
postoperatively. The prevalence of reoperations, revisions and mortality was also recorded at a mean of 5 years
postoperatively.
Results: There were no significant differences in the midterm postoperative OKS (P = 0.83), Tegner score (P = 0.17)
and AKSS-O (P = 0.67). However, the AKSS-F was significantly higher (P = 0.04) in normal (90, IQR 37.5) compared to
osteoporotic (65, IQR 35) groups. There were no significant differences (P = 0.82) between normal and osteopenic
bone (80, IQR 35). The revision prevalence was 5%, 2.6% and 0% in the normal, osteopenic and osteoporotic groups
respectively. The reoperation prevalence was 5%, 7.9% and 0% respectively. There were no deaths in any group
related to the implant.
Conclusions: We found that patients with reduced BMD could safely undergo cementless UKR surgery and have
similar clinical outcomes to those with normal BMD. However, larger studies with longer follow-up are needed to
confirm our findings and ensure that cementless fixation is safe in patients with reduced BMD.
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Background
Over 100,000 primary knee replacements are conducted
annually in the UK for end-stage osteoarthritis [1]. These
include total knee replacement (TKR) and unicompart-
mental knee replacement (UKR), where one compartment
is replaced. Both TKR and UKR can be implanted with or
without bone cement. Most knee replacement research
has focused on implant design rather than the quality of
bone that the implants are inserted into.
Osteoporosis and its milder form, osteopenia, are condi-
tions characterised by reduced bone mineral density
(BMD) in otherwise normal bones, rendering them more
fragile and fracture prone [2]. They are estimated to affect
over 200 million people worldwide costing 37 billion euros
annually in Europe alone [3, 4]. Their prevalence is in-
creasing as the population is ageing. Although osteoarth-
ritis and reduced BMD have been considered to be
mutually exclusive, recently, it has been shown that both
conditions can coexist [5–7]. Current estimates are that
approximately 10% of patients undergoing hip or knee re-
placement surgery have a diagnosis of osteoporosis and up
to approximately 30% have evidence of osteopenia [5].
There are concerns that patients with reduced BMDs
will suffer worse outcomes after joint replacement surgery
[8, 9]. Surgeons are particularly concerned regarding
cementless implants, given they rely on press fit fixation
in the surrounding bone for primary stability [10]. Bio-
mechanical studies using polyurethane bone analogues
suggest that implant stability is directly related to BMD
for cementless implants and where BMD is reduced, fix-
ation is greatly enhanced by the addition of cement [11].
As a result, cementless implants are generally reserved for
younger patients with higher BMDs [12]. Despite these
concerns, there have been no studies investigating the
clinical outcomes of patients with reduced BMDs.
Our study aim was to determine whether patients with
reduced BMD have worse clinical outcomes following
uncemented UKR than those with normal BMD. Our
null hypothesis was that there would be no difference in
outcome between patients with normal and low BMD.
We report the midterm outcomes of a prospective co-
hort of normal, osteopenic and osteoporotic patients
undergoing cementless UKR surgery.
Methods
Between August 2006 and February 2017, a consecutive
series of 70 patients with central dual-energy X-ray ab-
sorptiometry (DEXA lumbar spine, hip and femoral
neck) as part of their routine clinical care underwent
medial cementless Oxford Phase 3 UKR (Zimmer Bio-
met, Swindon, UK). The patients had DEXA scans be-
cause they were considered at risk of fragility fracture
according to guidelines published by the National
Institute of Clinical Excellence (NICE) and were not re-
lated to UKR surgery [13].
Surgery was performed through a minimally invasive
approach by two surgeons involved in the design of the
implant (DWM, CAD). The recommended indications
and surgical technique were used [14, 15]. The indica-
tions for surgery were anteromedial osteoarthritis or
avascular necrosis with functionally intact ligaments.
Osteoporosis and osteopenia were not considered to be
contraindications. The only exclusion criteria were pa-
tients without a DEXA scan.
Patients were categorised into three groups based on
their T scores from their DEXA scans. From the three
regions (lumbar spine, hip, femoral neck), the lowest
mean T scores were used to diagnose patients as per
WHO recommendations [16] into (1) normal bone, (2)
osteopenic bone or (3) osteoporotic bone (Table 1).
Baseline characteristics including age, body mass index
(BMI), gender and American Society of Anaesthiologists
(ASA) grade were recorded. All patients were followed
up by research physiotherapists independent to the sur-
gical and clinical teams caring for the patients by clinic
appointments, postal questionnaires or telephone calls.
Outcome scores including the Oxford Knee Score (OKS)
[17], American Knee Society Objective Score (AKSS-O)
[18], American Knee Society Functional Score (AKSS-F)
[18] and the Tegner Activity Score [19] were recorded
preoperatively and regularly postoperatively at a mean of
4 years. The AKSS-O was calculated, as previously de-
scribed [20], without deductions if the alignment was
not neutral, as the Oxford UKR does not aim to achieve
neutral alignment like TKR, but aims to restore pre-
disease alignment, which is commonly varus. The status
of the replacements was assessed by a full-time research
physiotherapist and data manager, by contacting patients
directly and screening hospital and other records. The
prevalence of revision, reoperation and patient mortality
were recorded as they occurred. Revision was defined as
the removal or addition of any implant component. Re-
operation was defined any surgical intervention whatso-
ever to the knee and included all revisions.
All study data is recorded in an electronic database
and updated in real time by a full time data manager
and was extracted on 14th August 2018.
Table 1 WHO definitions of normal bone, osteopenia and
osteoporosis used to interpret central dual-energy X-ray
absorptiometry scans
Bone status T score
Normal T≥ − 1.0
Osteopenia − 2.5 < T < − 1.0
Osteoporosis T≤ − 2.5
Mohammad et al. Journal of Orthopaedic Surgery and Research           (2020) 15:35 Page 2 of 6
Statistical analysis
Non-parametric statistics were used to compare patient-
reported outcome measures as these were not normally
distributed.
To analyse differences in functional scores pre- and post-
operatively, the Wilcoxon matched signed-rank test was uti-
lised. To compare the postoperative scores between groups,
the Kruskal-Wallis test was utilised. The post hoc Dunn test
was utilised if the Kruskal-Wallis test approached statistical
significance. The OKS functional and pain subscales were
calculated according to the published recommendations
[21]. The Kruskal-Wallis test was used to compare for base-
line differences between groups (Table 2). The prevalence of
reoperations, revisions and deaths are reported as a percent-
age of the total number of patients in that group.
Statistical analyses were all performed in Stata version
14 (STATA Corp, TX). Statistical significance was set at
P ≤ 0.05.
Results
Overall results from cohort
Seventy medial Oxford UKRs were implanted in 70 patients
(60 females and 10 males). The indications for surgery were
anteromedial osteoarthritis in 65 patients and spontaneous
osteonecrosis of the knee in 5 patients. Thirty-six UKRs were
right sided and 34 were left sided. The mean age at surgery
was 68.0 years (SD 9.5) and mean BMI was 28.1 (SD 5.5).
The mean follow-up of patients for information about
revision and reoperation 5 years (SD 2.6) and for post-
operative scores was 4 years (SD 2.5). No patient was
lost to follow-up, but one patient withdrew from regular
follow-up due to poor general health after 7 years
follow-up. From the 70 patients, 20 met the definition
for normal bone, 38 had osteopenic bone and 12 had
osteoporotic bone as per the WHO criteria [16]. There
were no significant differences in the baseline demo-
graphics of the three groups except age (Table 2).
The mean and median preoperative OKS was 21.7 (SD
8.3) and 22 (IQR 13) which increased significantly (P <
0.001) postoperatively to 38.3 (SD 10.8) and 43 (IQR 12).
The mean and median and preoperative Tegner score was
1.8 (SD 1) and 2 (IQR 2) which increased significantly
(P = 0.02) to 2.4 (SD 1.4) and 2 (IQR 2) postoperatively.
The mean and median preoperative AKSS O was 54.1 (SD
13.8) and 54 (IQR 19) and increased significantly (P <
0.001) to 87.5 (SD 16.3) and 93 (IQR 10) postoperatively.
The mean and median preoperative AKSS F was 63.6 (SD
14.6) and 62.5 (IQR 15) which increased significantly (P <
0.001) to 74.8 (SD 24.3) and 80 (IQR 40) postoperatively.
Sixty-four patients had no significant event of interest
during the duration of the study. There were four reo-
perations during the study which included two revisions.
The reoperations included two arthroscopies (one for
pain and the other for a torn lateral meniscus) and two
revisions, one of which was a conversion to TKR follow-
ing a lateral tibial plateau fracture following a traumatic
fall and a bearing exchange for a bearing dislocation.
There were two deaths unrelated to surgery.
Comparison of the normal, osteopenic and osteoporotic
groups
There were no significant differences in the postoperative
OKS, OKS function subscales, OKS pain subscales, and
Tegner and AKSS-O scores of the normal, osteopenic and
osteoporotic groups (Table 3). There was a significant differ-
ence (P= 0.04) between in the postoperative AKSS-F be-
tween the normal (mean = 78.4, median = 90) and
osteoporotic groups (mean = 60.5, median = 65). The
Table 2 Comparisons of baseline characteristics between groups. The Kruskal-Wallis test was used to compare all variables except
gender which was compared with the Fisher’s exact test. Mean (SD) and Median (IQR) values for patient reported outcome
measures are shown
Parameter Normal bone Osteopenic bone Osteoporotic bone Differences between
groups for parameter
Mean follow-up (years) 4.7 (SD 2.4) 4.7 (SD 2.5) 6.6 (SD 3) P = 0.16
Age 62.9 (SD 8.1) 70.4 (SD 9.7) 68 (SD 8.3) P = 0.01
BMI 30.9 (SD 6.3) 27 (SD 4.5) 27.1 (SD 5.7) P = 0.06
Gender 15 females, 5 males 34 females, 4 males 11 females, 1 male P = 0.34
ASA grade 2.25 (SD 0.6) 2.16 (SD 0.5) 2.17 (SD 0.4) P = 0.76
Preop mean and median OKS 19.3 (SD 7.8), 17 (IQR 11) 23.1 (SD 8.8), 23.5 (IQR 15) 20.4 (SD 7.5), 20.5 (IQR 9) P = 0.37
Preop mean and median OKS functional
subscale score
10 (SD 3.8), 10 (IQR 6) 11 (SD 3.9), 11 (IQR 6) 11.3 (SD 3.7), 12 (IQR 6) P = 0.58
Preop mean and median OKS pain
subscale score
10.5 (SD 5), 10 (IQR 9) 11.1 (SD 5.1), 10 (IQR 7) 11.7 (SD 5.5), 13 (IQR 7) P = 0.80
Preop mean and median Tegner 1.7 (SD 1.4), 2 (IQR 3) 1.9 (SD 0.9), 2 (IQR 2) 1.5 (SD 1), 1.5 (IQR 1) P = 0.70
Preop mean and median AKSS-O 48.7 (SD 14.2), 50 (IQR 14) 58 (SD 12.8), 59.5 (IQR 16.5) 50 (SD 14.5), 48 (IQR 11) P = 0.18
Preop mean and median AKSS-F 62.1 (SD 16.8), 62.5 (IQR 12.5) 65.1 (SD 14.3), 70 (IQR 15) 60 (SD 12.6), 60 (IQR 15) P = 0.74
Mohammad et al. Journal of Orthopaedic Surgery and Research           (2020) 15:35 Page 3 of 6
osteoporotic group had a lower AKSS-F than the osteopenic
(mean 77.8, median 80) group, but this did not reach statis-
tical significance (P= 0.07). No differences (P= 0.82) existed
in AKSS-F between the osteopenic and normal group.
In the normal bone group (n = 20), there was one re-
operation (5%) which also classified as a revision (5%) at
2.2 years follow-up. A 57-year-old female with a BMI of
37.4 fell awkwardly onto a wet surface and sustained a
lateral tibial plateau fracture which required conversion
to a TKR with a stemmed tibial component. There were
no deaths in this group.
In the osteopenic bone group (n = 38), there were three
reoperations (7.9%) which included one revision (2.6%).
The three reoperations were as follows: one arthroscopy
in a 61-year-old female at 2.4 years post-operatively for
pain with no significant intraoperative findings, one arth-
roscopy in a 58-year-old female at 4.8 years post-
operatively for a lateral meniscal tear with intraoperative
findings of a torn discoid lateral meniscus with haemar-
throsis, and one bearing exchange in a 42-year-old female
at 1.5 years post-operatively following anterior bearing dis-
location with intraoperative findings of the bearing in the
suprapatellar pouch. Two patients died in the osteopenic
group during the study at 2.8 and 4.5 years post-
operatively from causes not related to the implant (2.6%).
In the osteoporotic group (n = 12), there were no reo-
perations (0%), revisions (0%) or deaths (0%) during the
duration of the study.
Discussion
This is the first study to report the midterm outcomes
of knee replacement surgery in patients with reduced
BMD according to the WHO criteria [16]. The main
finding of the study was that there was no increased re-
vision or reoperation rate or pain following cementless
UKR in patients with osteopenia or osteoporosis com-
pared to controls with normal BMD. This suggests that
osteopenia and osteoporosis should not be considered to
be a contraindication to cementless Oxford UKR.
After the initial assessment of the cementless Oxford
UKR, the surgeons involved with this study used
cementless rather than cemented fixation for all medial
UKR so as to determine if there was a subgroup of pa-
tients in which cementless fixation was not appropriate.
Osteopenia and osteoporosis were not considered to be
contra-indications, and BMD was not part of the pre-
operative assessment. Furthermore, even if at operation
the bone was found to be soft or the tibial component
did not feel solid, cementless fixation was used. Inde-
pendent of the UKR, if patients were considered to be at
risk of fragility fractures, their general practitioners ar-
ranged BMD assessments. We identified cementless
UKR with BMD assessments and subdivided these into
normal, osteopenia and osteoporosis.
At mean follow-up of 5 years, there were no significant
differences in the prevalence of reoperation or revision sur-
gery between the groups. Overall, there was a trend towards
decreasing revision and reoperation rates with decreasing
BMD, with the revision rate in the normal, osteopenic and
osteoporotic groups being respectively 5%, 2.6% and 0%.
Furthermore, there were no cases with loosening and the
only fracture was in the normal bone group, which was a
lateral tibial fracture at 2 years due to trauma. As the num-
bers in the study are relatively small, the study is under-
powered to detect small differences in revision and
reoperation rate. However, in view of the results, it is un-
likely that there is a major problem with, for example, high
loosening or fracture rates associated with decreased BMD.
There were no significant differences in post-operative
outcome scores between the groups for OKS, including
functional and pain subscales, Tegner and AKSS-O,
which includes an assessment of pain. However, the
osteoporotic group had a significantly lower (P = 0.04)
AKSS-F compared to the normal bone group. The
AKSS-F score does not assess pain, so we can con-
clude that osteopenia and osteoporosis does not com-
promise the improvement in pain achieved by
cementless UKR.
Table 3 Comparisons of PROM scores taken at a mean of 4 years postoperatively. The Kruskal-Wallis test was used to test for
significant differences between groups *Post hoc testing revealed significant differences between normal and osteoporotic
bone group's AKSS-F scores (P=0.04)
Parameter Normal bone Osteopenic bone Osteoporotic bone Differences between
groups for parameter
Mean and median OKS 37 (SD 12.1), 42.5 (IQR 14) 38.9 (SD 10), 43 (IQR 9) 38.5 (SD 11.5), 42.0 (IQR 17) P = 0.83
Mean and median OKS functional subscale
score
14.6 (SD 5), 17 (IQR 7.5) 15.5 (SD 4.3), 17 (IQR 6) 14.8 (SD 5.4), 16.5 (IQR 9) P = 0.79
Mean and median OKS pain subscale
score
22.4 (SD 7.5), 26.5 (IQR 8) 23.4 (SD 6.4), 26 (IQR 7) 23.4 (SD 6.3), 26 (IQR 7) P = 0.93
Mean and median Tegner 2.9 (SD 1.8), 3 (IQR 2) 2.4 (SD 1.2), 2.5 (IQR 2) 1.7 (SD 1.3), 2 (IQR 1) P = 0.17
Mean and median AKSS-O 89.6 (SD 13.2), 95 (IQR 20) 85.9 (SD 19), 93 (IQR 7) 90 (SD 7.1), 93 (IQR 6) P = 0.67
Mean and median AKSS-F 78.4 (SD 29), 90 (IQR 37.5) 77.8 (SD 20.4), 80 (IQR 35) 60.5 (SD 25.3), 65 (IQR 35) P = 0.07*
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It is not clear whether there is a compromise in func-
tion associated with osteoporosis. Although the AKSS-F
was significantly lower with osteoporosis than the nor-
mal bone, the OKS functional subscale was not signifi-
cantly different. Therefore, the AKSS-F finding could be
a result of multiple testing (type 2 error) or it could be
because the functional assessment is different from that
of the OKS. The OKS functional subscale [17] asks pa-
tients questions about how their knee affects their ability
to do everyday activities such as washing, getting into
and out of a car, kneeling and going down stairs. In con-
trast, the AKSS-F [18] asks about the absolute distance a
patient can walk, the mechanism of mobilisation up and
down the stairs and whether they use mobility aids. Pa-
tients with a diagnosis of osteoporosis are more likely to
be suffering from undiagnosed fragility fractures and other
cardiorespiratory morbidities than those with the normal
bone. These co-morbidities are probably more likely to
affect their absolute walking distance and mechanisms of
mobilising [22–24], rather than the compromise in every-
day activities due to the knee. Therefore, even if there is a
compromise in function with osteoporosis, it is unlikely to
be related to cementless fixation of the UKR.
It is perhaps surprising that osteoporosis and osteopenia
do not compromise the outcome of cementless medial mo-
bile bearing UKR. The likely explanation is that patients
with medial arthritis have varus in the knee and often pre-
existing tibia vara. As a result, they will have increased load-
ing through the medial compartment of the knee, which
will preserve bone quality medially allowing cementless fix-
ation, even if there is a central decrease in BMD [25–27].
Furthermore, with the mobile bearing, the loads on the
bone-implant interface are predominantly compressive
which is ideal for cementless fixation [28]. Studies of the
Oxford knee have shown that the BMD of proximal tibia is
preserved after the operation [29, 30]. In contrast following
TKR, the BMD can reduce by up to 57% following surgery
[31]. Therefore, the finding that it is safe to use cementless
fixation for the Oxford knee in osteoporosis or osteopenia
may not apply to other implants.
One of the main strengths of the study is that all patients
had a central DEXA scan and we did not just assess the
peri-prosthetic bone like previous studies [12, 32]. There is
a general consensus that the most appropriate regions for
assessing patients for osteopenia and osteoporosis is by
using central DEXA measurements from the spine and hip
given these conditions are systemic [33, 34].
The study does have its limitations: the study was
small with 40 patients having osteopenia or osteoporosis
and was therefore underpowered for failure as an end-
point. To undertake an appropriately powered study to
identify a small increased risk of failure in osteoporosis
would be very difficult as it would require many thou-
sands of patients, and many of these would have to be
screened for BMD. Another limitation, as discussed
above, was that we only assessed patients that had
DEXA scans rather than doing DEXA scans in all
cementless cases, so there is potential for selection bias
[13]. Additionally, our study did not have radiographic
follow-up. Finally, we did not have full information on
whether patients diagnosed with clinically significant re-
duced BMD were commenced on medical treatment,
but given adherence to medical therapy is widely re-
ported as being poor [35, 36]; we would not expect this
to influence our results.
Conclusions
In conclusion, we found that patients with osteopenia
and osteoporosis can safely have cementless Oxford
UKR, and following surgery had similar outcome scores
to those with the normal bone. We recognise that our
study is small and that larger studies are needed to con-
firm our findings. Therefore, until these are done, sur-
geons should be cautious with cementless UKR fixation
in osteoporotic bone, even though the evidence suggests
it is safe.
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